Tederic(SH:603289)2023-04-14 16:00Financial Performance - The net profit attributable to ordinary shareholders for 2022 was ¥96,638,711.32, with a distributable profit of ¥517,080,008.92 as of December 31, 2022[6]. - The company's operating revenue for 2022 was ¥1,185,897,336.97, representing an increase of 8.05% compared to ¥1,097,586,525.42 in 2021[23]. - The net profit attributable to shareholders for 2022 was ¥96,638,711.32, a decrease of 32.05% from ¥142,213,445.28 in 2021[23]. - The net cash flow from operating activities was ¥7,673,817.85, down 96.34% from ¥209,910,411.00 in the previous year[23]. - The total assets at the end of 2022 were ¥1,989,534,390.03, reflecting a growth of 5.35% from ¥1,888,508,864.73 at the end of 2021[23]. - The overall gross profit margin for 2022 was 26.31%, a decrease of 3.13 percentage points compared to the previous year[75]. - The company reported a decrease of 18.91% in net profit after deducting non-recurring gains and losses, totaling ¥97,510,342.81 in 2022[23]. - The company maintained a healthy financial position with a debt-to-asset ratio of 32.15% and no interest-bearing debt[75]. Profit Distribution - The proposed profit distribution plan for 2022 includes a cash dividend of ¥1.50 per 10 shares (tax included), with no capital reserve transfer to increase share capital or issuance of bonus shares[6]. - The cash dividend distribution represents 45.51% of the net profit attributable to ordinary shareholders[159]. - The total cash distribution, including share repurchase, amounts to CNY 66,252,604.97, which is 68.55% of the net profit[159]. - The independent directors support the profit distribution plan, emphasizing its alignment with the company's sustainable development and investor returns[156]. - The company has established a clear cash dividend policy that complies with its articles of association and relevant regulations[157]. Research and Development - The company invested 62.06 million RMB in R&D during the reporting period, which is a 13.56% increase from the previous year, focusing on high-end market replacement[34]. - Research and development expenses increased by 13.56% to CNY 62.06 million, reflecting the company's commitment to innovation and product development[77]. - The total R&D expenditure for the period was ¥62,064,185.20, accounting for 5.23% of the operating revenue[88]. - The number of R&D personnel is 135, representing 14.93% of the total workforce[89]. Market and Sales - Domestic sales revenue reached CNY 714.26 million, growing by 9.13% and accounting for 60.23% of total revenue; international sales revenue was CNY 471.64 million, up 6.44% and representing 39.77% of total revenue[75]. - The company is a major supplier of injection molding machines in China, recognized as one of the top 15 enterprises in the plastic injection molding machine industry from 2011 to 2022[44]. - The injection molding machine market in China has seen a significant increase in export volume, with 57,000 units exported and an export value of $1.49 billion in the first 11 months of 2022, far exceeding imports of 6,354 units valued at $550 million[42]. - The company has established a global marketing service network with subsidiaries in Portugal, Mexico, South Korea, and Brazil, covering 38 countries[72]. Corporate Governance - The board of directors has ensured the authenticity, accuracy, and completeness of the annual report[4]. - The company has not reported any instances of more than half of the directors being unable to guarantee the authenticity of the annual report[8]. - The company has not faced any penalties from securities regulatory agencies in the past three years[140]. - The company has a diverse board with members holding positions in various other organizations, enhancing its governance structure[136]. Risks and Challenges - The company's performance is at risk due to fluctuations in downstream industries, particularly in sectors like automotive parts, logistics packaging, and home appliances, which could negatively impact revenue growth[118]. - Increased competition in the mid-to-high-end injection molding machine market may lead to a decline in gross margins and profitability, as competitors like Engel and KraussMaffei hold larger market shares[119]. - The company faces customer acquisition risks due to a relatively dispersed customer base, which complicates management and increases market development costs[119]. - Fluctuations in raw material prices, particularly steel, can significantly impact production costs, complicating cost control efforts[122]. Strategic Initiatives - The company plans to continue focusing on product development and market expansion strategies in the upcoming year[23]. - The company is committed to enhancing its technological capabilities and exploring potential mergers and acquisitions to drive growth[23]. - The company is actively involved in research and development of new products and technologies to align with national policies promoting smart manufacturing and digital transformation[41]. - The company is pursuing a global development strategy, aiming to strengthen its global R&D, branding, manufacturing, marketing, and service systems[111]. Environmental and Social Responsibility - The company invested CNY 300,000 in environmental protection during the reporting period[166]. - The company did not report any environmental violations or penalties during the reporting period[167]. - The company is committed to sustainable development, ensuring a product lifecycle strategy of "selling one generation, reserving one generation, and researching one generation" to lay a foundation for the next five to ten years[110]. Financial Management - The company approved a financial management plan allowing the use of up to 600 million RMB of idle funds for purchasing financial products[196]. - The total amount of financial products managed by the company reached 524.7 million RMB, with an outstanding balance of 273.32 million RMB[197]. - The company has no overdue amounts from its financial management activities[197]. Employee and Talent Development - The company has implemented a comprehensive training program, including the "Eagle" plans, aimed at developing talent for various levels within the organization[151]. - The company's compensation policy includes a base salary and performance bonuses, with regular assessments to ensure alignment with industry standards and employee performance[150]. - The total number of employees in the parent company and major subsidiaries is 904, with 585 in the parent company and 319 in subsidiaries[149].